Clinical Trials

Chronic traumatic encephalopathy

Displaying 2 studies

  • A Study Of Neurobehavioral Dysregulation Questionnaire (NBD‑Q) In DIAGNOSE CTE‑II Scottsdale/Phoenix, AZ

    The purpose of this study is to evaluate the psychometric properties of the newly developed Neurobehavioral Dysregulation Questionnaire (NBD‑Q) in the DIAGNOSE CTE‑II cohort at Mayo Clinic Arizona to inform its inclusion as a study measure for neurobehavioral dysregulation in TES/CTE research.

  • The DIAGNOSE CTE Research Project-II Scottsdale/Phoenix, AZ

    The purpose of this study aims to retain and grow DIAGNOSE-I and examine the clinical and biomarker course of TES; investigate risk and resilience factors of TES; and compare biomarkers of amyloid (Aβ), p-tau, neurodegeneration, neuroinflammation, and white matter (WM) injury between TES and AD.

.

Mayo Clinic Footer